REMS:风险评估和缓解策略
“风险评估和缓解策略”(Risk Evaluation and Mitigation Strategy)在专业领域常被缩写为REMS,以提升书写和沟通效率。这一术语在美国食品药品监督管理局(FDA)等相关机构中尤为常见,主要用于指代为确保药物和生物制品的安全使用而制定的一套风险管理计划。通过REMS,监管机构和制药企业能够系统性地识别、评估并采取措施降低特定医疗产品的潜在风险。
Risk Evaluation and Mitigation Strategy具体释义
Risk Evaluation and Mitigation Strategy的英文发音
例句
- Risk Evaluation and Mitigation Strategy(REMS) ( REMS ) has been developed to address the risks of Nplate therapy.
- 风险评估和减轻战略(REMS)已发展到Nplate治疗的风险评估中。
- Because of these safety concerns, a risk evaluation and mitigation strategy has been implemented to educate patients and clinicians regarding the safe use and risks of everolimus.
- 基于这些安全性的考虑,研究者们正在进行一些危险评估和缓解策略,从而对患者和临床医生进行依维莫司安全使用和危险因素的相关教育。
- Drugs for which a Risk Evaluation and Mitigation Strategy(REMS) has been implemented to ensure that the benefits of use outweigh the risks;
- 为确保药品使用利益大于风险所实施的药品风险评估和处理策略;
- The FDA has notified the manufacturers of these drugs that a Risk Evaluation and Mitigation Strategy(REMS) ( REMS ) is necessary to ensure that the benefits of the drug outweigh the risks.
- FDA已通知制造商,这些药物的风险评估和减轻战略是必要的,以确保药物的好处大于风险。
- Manufacturers will be required to implement a risk evaluation and mitigation strategy, or REMS, to ensure patients are provided with a medication guide that discusses this risk.
- 生产厂商将被要求制定出预案,即风险评估和应对策略的措施以保证患者能得到有关该风险医疗指导的保护。
本站英语缩略词为个人收集整理,可供非商业用途的复制、使用及分享,但严禁任何形式的采集或批量盗用
若REMS词条信息存在错误、不当之处或涉及侵权,请及时联系我们处理:675289112@qq.com。